KZR

$0.00

(

+0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Kezar Life Sciences Inc

NASDAQ | KZR

6.22

USD

+$0.00

(

+0.00%

)

At Close (As of Dec 3, 2025)

$45.04M

Market Cap

-

P/E Ratio

-8.44

EPS

$7.25

52 Week High

$3.53

52 Week Low

HEALTHCARE

Sector

KZR Chart

Recent Chart
Price Action

KZR Technicals

Tags:

KZR Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -$1M
Total Revenue $0
Cost Of Revenue $1M
Costof Goods And Services Sold $1M
Operating Income -$91M
Selling General And Administrative $23M
Research And Development $66M
Operating Expenses $91M
Investment Income Net -
Net Interest Income $6.9M
Interest Income $8.5M
Interest Expense $1.6M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $1M
Income Before Tax -$84M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$84M
Comprehensive Income Net Of Tax -
Ebit -$82M
Ebitda -$81M
Net Income -$84M

Revenue & Profitability

Earnings Performance

KZR Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $145M
Total Current Assets $137M
Cash And Cash Equivalents At Carrying Value $42M
Cash And Short Term Investments $42M
Inventory -
Current Net Receivables $424K
Total Non Current Assets $7.2M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments -
Short Term Investments $90M
Other Current Assets $4.8M
Other Non Current Assets -
Total Liabilities $28M
Total Current Liabilities $20M
Current Accounts Payable $3.7M
Deferred Revenue -
Current Debt -
Short Term Debt $8.7M
Total Non Current Liabilities $7.4M
Capital Lease Obligations $5.9M
Long Term Debt $5.1M
Current Long Term Debt $5.2M
Long Term Debt Noncurrent -
Short Long Term Debt Total $16M
Other Current Liabilities $7.9M
Other Non Current Liabilities -
Total Shareholder Equity $117M
Treasury Stock -
Retained Earnings -$434M
Common Stock $7K
Common Stock Shares Outstanding $73M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$74M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $1M
Capital Expenditures $29K
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment $80M
Cashflow From Financing $103K
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$84M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -$1M
Total Revenue $0
Cost Of Revenue $1M
Costof Goods And Services Sold $1M
Operating Income -$91M
Selling General And Administrative $23M
Research And Development $66M
Operating Expenses $91M
Investment Income Net -
Net Interest Income $6.9M
Interest Income $8.5M
Interest Expense $1.6M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $1M
Income Before Tax -$84M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$84M
Comprehensive Income Net Of Tax -
Ebit -$82M
Ebitda -$81M
Net Income -$84M

KZR News

KZR Profile

Kezar Life Sciences Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Kezar Life Sciences, Inc. is an innovative clinical-stage biotechnology firm based in South San Francisco, California, specializing in the advancement of small molecule therapies aimed at immune-mediated diseases and cancer. By harnessing its proprietary drug discovery platform, the company is dedicated to meeting urgent medical needs, with a robust and varied pipeline of candidates currently undergoing clinical evaluation. Kezar's strategic emphasis on addressing complex therapeutic challenges positions it as a frontrunner in the biopharmaceutical landscape, with the potential to significantly enhance patient outcomes and transform treatment paradigms in pivotal disease areas.

LPTX
+368.57%
$2.05
PAVS
-38.29%
$0.03
VRAX
+49.12%
$0.58
IXHL
+16.01%
$0.46
IRBT
+63.24%
$3.18
VHAI
0.00%
$0.00
TWOH
0.00%
$0.00
ONDS
-1.47%
$7.95
NVDA
-0.47%
$180.60
IPG
-1.95%
$24.57
AXDX
-61.36%
$0.03
NIO
-5.45%
$4.75
PLUG
+3.08%
$2.17
TSLA
+4.23%
$447.43
KITT
+53.62%
$1.11
BYND
-7.01%
$1.19
BITF
-1.77%
$3.04
ADAP
-15.14%
$0.05
ASST
-2.41%
$1.01
INTC
+0.21%
$43.56
RR
+11.93%
$3.98
IREN
+7.36%
$44.15
CAPR
+385.06%
$30.85
QCLS
+39.56%
$4.71
SOND
-23.45%
$0.12
YGMZ
-21.06%
$0.08
RMBL
+60.50%
$3.21
LNW
-3.71%
$86.22
ADD
-25.47%
$0.05
IVP
-0.62%
$0.12
MRVL
+6.22%
$98.67
BMNR
+3.68%
$33.08
INHD
-7.67%
$0.13
SRM
+53.27%
$10.30
BMNU
+4.90%
$7.70
AAL
+1.79%
$14.49
DNN
+2.70%
$2.66
NFLX
-5.40%
$103.43
T
-1.04%
$25.52
PFE
+1.89%
$25.62
VALE
+1.57%
$12.89
WLGS
-5.57%
$0.04
SOFI
+0.44%
$29.64
MTSR
-0.35%
$70.50
BBD
-2.22%
$3.58
F
+1.19%
$13.11
AEO
+13.53%
$23.64
AFMD
-34.94%
$0.18
ACHR
+4.37%
$7.98
MARA
+2.97%
$12.26
CIFR
+2.29%
$18.04
QBTS
+5.45%
$23.72
AVGO
-1.16%
$381.57
PLTD
-2.15%
$6.80
AAPL
-0.14%
$285.77
IMRN
-10.05%
$1.56
WULF
-1.14%
$14.05
BTBT
+0.24%
$2.24
KVUE
-0.41%
$16.79
ASBP
-8.60%
$0.09
CLSK
+3.17%
$14.14
PMAX
+24.22%
$2.82
CHR
-5.80%
$0.04
GOOGL
+1.75%
$321.35
HTOO
+6.74%
$3.73
AMD
+0.69%
$216.72
MSFT
-1.60%
$482.11
CMND
-12.88%
$0.11
GRYP
-10.38%
$1.38
BTE
-1.55%
$3.17
MODV
-25.22%
$0.43
AMZN
-0.93%
$232.23
PCG
-1.37%
$15.11
JOBY
+2.67%
$13.83
PLTR
+1.93%
$173.99
RIG
+3.03%
$4.44
PYPL
-2.46%
$61.35
HOOD
+5.27%
$132.59
AKTX
-14.10%
$0.34
RIVN
+0.20%
$17.26
M
+1.91%
$23.14
BMY
+5.66%
$50.98
HBAN
+2.64%
$16.99
VIVK
-13.71%
$0.09
BTG
+0.81%
$4.46
MSTR
+2.68%
$186.20
CRCL
+7.27%
$83.07
RGTI
+2.15%
$24.39
NOK
+0.40%
$6.21
ALIT
-1.12%
$2.20
KDLY
-2.95%
$0.48
DVLT
-4.79%
$1.78
BAC
+1.52%
$54.00
SAND
-6.04%
$12.12
PSTG
-26.52%
$69.59
GPUS
-5.64%
$0.27
SHOT
-74.37%
$0.39
ZAPP
-46.30%
$0.15
ARTL
-2.77%
$1.75
SNAP
+0.06%
$7.62
LPTX
+368.57%
$2.05
PAVS
-38.29%
$0.03
VRAX
+49.12%
$0.58
IXHL
+16.01%
$0.46
IRBT
+63.24%
$3.18
VHAI
0.00%
$0.00
TWOH
0.00%
$0.00
ONDS
-1.47%
$7.95
NVDA
-0.47%
$180.60
IPG
-1.95%
$24.57
AXDX
-61.36%
$0.03
NIO
-5.45%
$4.75
PLUG
+3.08%
$2.17
TSLA
+4.23%
$447.43
KITT
+53.62%
$1.11
BYND
-7.01%
$1.19
BITF
-1.77%
$3.04
ADAP
-15.14%
$0.05
ASST
-2.41%
$1.01
INTC
+0.21%
$43.56
RR
+11.93%
$3.98
IREN
+7.36%
$44.15
CAPR
+385.06%
$30.85
QCLS
+39.56%
$4.71
SOND
-23.45%
$0.12
YGMZ
-21.06%
$0.08
RMBL
+60.50%
$3.21
LNW
-3.71%
$86.22
ADD
-25.47%
$0.05
IVP
-0.62%
$0.12
MRVL
+6.22%
$98.67
BMNR
+3.68%
$33.08
INHD
-7.67%
$0.13
SRM
+53.27%
$10.30
BMNU
+4.90%
$7.70
AAL
+1.79%
$14.49
DNN
+2.70%
$2.66
NFLX
-5.40%
$103.43
T
-1.04%
$25.52
PFE
+1.89%
$25.62
VALE
+1.57%
$12.89
WLGS
-5.57%
$0.04
SOFI
+0.44%
$29.64
MTSR
-0.35%
$70.50
BBD
-2.22%
$3.58
F
+1.19%
$13.11
AEO
+13.53%
$23.64
AFMD
-34.94%
$0.18
ACHR
+4.37%
$7.98
MARA
+2.97%
$12.26
CIFR
+2.29%
$18.04
QBTS
+5.45%
$23.72
AVGO
-1.16%
$381.57
PLTD
-2.15%
$6.80
AAPL
-0.14%
$285.77
IMRN
-10.05%
$1.56
WULF
-1.14%
$14.05
BTBT
+0.24%
$2.24
KVUE
-0.41%
$16.79
ASBP
-8.60%
$0.09
CLSK
+3.17%
$14.14
PMAX
+24.22%
$2.82
CHR
-5.80%
$0.04
GOOGL
+1.75%
$321.35
HTOO
+6.74%
$3.73
AMD
+0.69%
$216.72
MSFT
-1.60%
$482.11
CMND
-12.88%
$0.11
GRYP
-10.38%
$1.38
BTE
-1.55%
$3.17
MODV
-25.22%
$0.43
AMZN
-0.93%
$232.23
PCG
-1.37%
$15.11
JOBY
+2.67%
$13.83
PLTR
+1.93%
$173.99
RIG
+3.03%
$4.44
PYPL
-2.46%
$61.35
HOOD
+5.27%
$132.59
AKTX
-14.10%
$0.34
RIVN
+0.20%
$17.26
M
+1.91%
$23.14
BMY
+5.66%
$50.98
HBAN
+2.64%
$16.99
VIVK
-13.71%
$0.09
BTG
+0.81%
$4.46
MSTR
+2.68%
$186.20
CRCL
+7.27%
$83.07
RGTI
+2.15%
$24.39
NOK
+0.40%
$6.21
ALIT
-1.12%
$2.20
KDLY
-2.95%
$0.48
DVLT
-4.79%
$1.78
BAC
+1.52%
$54.00
SAND
-6.04%
$12.12
PSTG
-26.52%
$69.59
GPUS
-5.64%
$0.27
SHOT
-74.37%
$0.39
ZAPP
-46.30%
$0.15
ARTL
-2.77%
$1.75
SNAP
+0.06%
$7.62
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.